Piper Sandler Maintains Overweight on Guardant Health, Lowers Price Target to $190

Benzinga · 2d ago
Piper Sandler analyst David Westenberg maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $193 to $190.